Expertise

Pamela Vo brings over 18 years of HEOR experience in the pharmaceutical industry, showcasing a history of strategically translating ideas into impactful outcomes. She boasts a proven track record of peer-reviewed publications, significant achievements in market access and reimbursement, regulatory approvals, and successful clinical product adoption. Her expertise spans multiple therapeutic areas across the United States and international landscapes. Notably, Vo’s most recent position was as the Global HEOR & Access Evidence Executive Director at Novartis.

Prior to her tenure at Novartis, Vo held roles such as Worldwide HEOR Director within the Global Patient Access division at Novartis, and various leadership positions at Lundbeck and Abbott/AbbVie, where she managed diverse healthcare portfolios.

Vo holds a Doctor of Pharmacy degree and a Master of Pharmacoeconomics and Policy degree. She recently obtained certification in Immuno-Oncology from Harvard Medical School HMX Pro. Currently based in Switzerland, Vo looks forward to expanding EVERSANA’s scientific expertise across Europe, the U.S., and beyond.